Applied DNA to Participate in Fireside Chat at the 34th Annual ROTH Investor Conference

Rhea-AI Summary

Applied DNA Sciences (NASDAQ: APDN) announced a virtual fireside chat hosted by CEO Dr. James A. Hayward on March 14, 2022, during the 34th Annual Roth Investor Conference. The session will cover the company’s advancements in Polymerase Chain Reaction (PCR)-based DNA technologies. Key executives, including CFO Beth Jantzen and Clay Shorrock, will also conduct one-on-one investor meetings. Interested investors can request a meeting via email at oneononerequests@roth.com. Full details will be available on their website.

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, announced today that Chief Executive Officer Dr. James A. Hayward will host a virtual fireside chat with the Company's covering analyst, Managing Director and Senior Research Analyst Jonathan Aschoff, on Monday, March 14, 2022, at the 34^th Annual ROTH Investor Conference.

Dr. Hayward, Beth Jantzen, chief financial officer, and Clay Shorrock, executive director of business development, will also host scheduled virtual one-on-one meetings with investors during the event.

To request a one-on-one meeting with Applied DNA, please email oneononerequests@roth.com or contact your Roth sales representative.

34^th Annual Roth Investor Conference
Date: Monday, March 14, 2022
Time: 12:00 p.m. ET (9:00 a.m. ET)
Webcast: https://wsw.com/webcast/roth43/apdn/1811596

The fireside chat will be available for viewing and replay on the Investor Relations section of the Applied DNA website at www.adnas.com.

About Applied DNA Sciences

Applied DNA is commercializing LinearDNA™, its proprietary, large-scale polymerase chain reaction ("PCR")-based manufacturing platform that allows for the large-scale production of specific DNA sequences.

The LinearDNA platform has utility in the nucleic acid-based in vitro diagnostics and preclinical nucleic acid-based drug development and manufacturing market. The platform is used to manufacture DNA for customers as components of in vitro diagnostic tests and for preclinical nucleic acid-based drug development in the fields of adoptive cell therapies (CAR T and TCR therapies), DNA vaccines (anti-viral and cancer), RNA therapies, clustered regularly interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies.

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Key end-markets include textiles, pharmaceuticals and nutraceuticals, and cannabis, among others.

Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a high-throughput turnkey solution for population-scale COVID-19 testing. safeCircle is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies that increase testing efficiencies and provide for rapid turn-around-times.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company's common stock is listed on NASDAQ under the ticker symbol 'APDN,' and its publicly traded warrants are listed on OTC under the ticker symbol 'APPDW.'

Applied DNA is a member of the Russell Microcap® Index.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220310005505/en/

Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com

Web: www.adnas.com

Twitter: @APDN

Source: Applied DNA Sciences, Inc.

FAQ

When is the fireside chat with Applied DNA Sciences scheduled?

The fireside chat is scheduled for March 14, 2022, at 12:00 p.m. ET.

Who is hosting the virtual fireside chat for Applied DNA Sciences?

CEO Dr. James A. Hayward will host the virtual fireside chat.

What is the focus of the Applied DNA Sciences fireside chat?

The focus will be on developments in PCR-based DNA technologies.

How can investors request a one-on-one meeting with Applied DNA Sciences?

Investors can request a meeting by emailing oneononerequests@roth.com.

Where can I watch the fireside chat for Applied DNA Sciences?

The fireside chat can be viewed on the Investor Relations section of Applied DNA's website.

What type of technologies does Applied DNA Sciences specialize in?

Applied DNA specializes in polymerase chain reaction (PCR)-based DNA manufacturing and nucleic acid technologies.